Clinical trial
Use of Serum Proteome on the Early Diagnosis of Malignant Biliary-Pancreatic Disease
NCT00559598 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Serum Proteome on the Early Diagnosis of Malignant Biliary-Pancreatic Disease
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- April 30, 2009
- Enrollment
- 502 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
extrahepatic bile duct cancer, pancreatic cancer